Chlamydia & gonorrhea screening
What the major U.S. guidelines recommend, with a link to verify each at the source. A quick-reference summary for clinicians, not medical advice.
USPSTF · 2021 · Grade B
Screen sexually active women, including pregnant persons, age 24 and younger; age 25 and older only if at increased risk. Same applies to chlamydia and gonorrhea. Men: I statement (insufficient evidence to screen for either).
Verify at USPSTF →CDC · 2021
Screen all sexually active women under 25 annually; women 25+ if at increased risk. Pregnant women under 25, and 25+ at risk, screen at first prenatal visit. MSM: screen at least annually at sites of exposure (chlamydia: urethra, rectum; gonorrhea: urethra, rectum, pharynx); every 3 to 6 months if higher risk. Retest 3 months after treatment.
Verify at CDC →